Invenomic Capital Management LP EAF — GRAFTECH INTL LTD

Ownership history in Invenomic Capital Management LP  ·  9 quarters on record

AI Ownership Summary

Invenomic Capital Management LP reported GRAFTECH INTL LTD (EAF) in 9 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.12% in 2024 Q3. The latest visible filing shows EAF at 0.08% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this EAF ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Invenomic Capital Management LP's position in GRAFTECH INTL LTD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

EAF was reported at 0.08% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.12% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

EAF stock page Invenomic Capital Management LP fund profile Invenomic Capital Management LP full holdings
How Invenomic Capital Management LP held EAF — position size vs. price
% of Fund (quarterly)    EAF price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 REDUCED — — — 105,680 -1,355 -1.3% 0.08% $1.6M 2026-02-14 (Est.) $6.67
2025 Q3 REDUCED 90.4% +24.0% ❌ 107,035 -1,003,281 -90.4% 0.07% $1.4M 2025-11-14 $13.59
2025 Q2 REDUCED 11.3% +34.8% ❌ 1,110,316 -141,578 -11.3% 0.06% $1.1M 2025-08-14 $13.30
2025 Q1 REDUCED 12.7% +11.3% ❌ 1,251,894 -182,512 -12.7% 0.06% $1.1M 2025-05-15 $8.44
2024 Q4 REDUCED 13.6% -49.5% ✅ 1,434,406 -225,869 -13.6% 0.12% $2.5M 2025-02-14 $11.40
2024 Q3 REDUCED 16.3% +31.1% ❌ 1,660,275 -322,672 -16.3% 0.12% $2.2M 2024-11-14 $21.50
2024 Q2 ADDED — — — 1,982,947 +526,530 +36.2% 0.09% $1.9M 2024-08-14 $6.69
2024 Q1 ADDED — — — 1,456,417 +687,595 +89.4% 0.11% $2.0M 2024-05-15 $18.80
2023 Q4 INITIATED — — — 768,822 — — 0.08% $1.7M 2024-02-14 $13.40

🏢 Other funds also holding EAF

As of 2026 Q1 — sorted by position size

Benefit Street Partners LLC 3Y 7Y 5.6% YACKTMAN ASSET MANAGEMENT LP 3Y 7Y 0.1% FOUNDATION RESOURCE MANAGEMENT INC 3Y 7Y 0.08% AEGON USA Investment Management, LLC 3Y 7Y 0.08% Krilogy Financial LLC 3Y 7Y 0.01% Anchor Investment Management, LLC 0.0% Fortitude Family Office, LLC 0.0% Advocate Investing Services LLC 0.0% Raiffeisen Bank International AG 0.0% SBI Securities Co., Ltd. 0.0%

FAQ About Invenomic Capital Management LP and EAF

These are the practical questions this page is built to answer before you even open the full history table.

How long has Invenomic Capital Management LP reported owning EAF?

Invenomic Capital Management LP reported EAF across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported EAF position in Invenomic Capital Management LP's portfolio?

The largest reported portfolio weight for EAF was 0.12% in 2024 Q3.

What is the latest reported EAF position on this page?

The most recent filing on this page is 2025 Q4, when Invenomic Capital Management LP reported 105,680 shares, equal to 0.08% of portfolio, with an estimated market value of $1.6M.

What does the chart on this EAF ownership page compare?

The chart compares Invenomic Capital Management LP's quarterly EAF portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Invenomic Capital Management LP time their EAF position?

Based on 13F filing dates vs. subsequent EAF price moves, Invenomic Capital Management LP correctly timed 5 out of 8 reported position changes (62%). The annualised alpha on EAF relative to SPY over the holding period was -40.4%.

← Back to Invenomic Capital Management LP Holdings